17^th World Hematology & Blood Disorders Conference November 25-26, 2019 Paris, France

Immunohematology:

Immunohematology is also known as blood banking a branch of hematology that deals with the study of antigen-antibody reactions. Patients undergoing transfusion therapy are tested for their ABO and RhD blood groups and the presence of any antibodies that may cause a reaction between their plasma and donor red cells. 

Hematology Societies in Europe

Association of European Cancer Leagues, Europe; International Society of Pediatric Oncology, Europe; European Academy of Cancer Sciences, Europe; European Society of Surgical Oncology, Europe; Organization of European Cancer Institute, Europe; European Organization for Research and Treatment of Cancer, Europe;  European Prostate Cancer Coalition, Europe

Leukocytosis:

Leukocytosis is a condition wherein the count of the white blood cells will rise above the normal range in the blood. It is an inflammatory response mostly occurs due to the result of infection but may also occur due to certain parasitic infections or bone tumors as well as leukemia. It may cause due to recent surgery, steroid use, medication side effects or stress.

Hematology Societies in Europe

British Society for Haematology, Europe; European Cancer Organization: ECCO, Europe; ESMO: European Society for Medical Oncology, Europe; European Association for Cancer Research, Europe; Egyptian Society of Hematology and Research

Thrombocytopenia:

Thrombocytopenia is a disorder in which you have a low blood platelet count. Thrombocytes are colourless blood cells that help blood clot. It may cause due to decreased production, increased destruction, pregnancy, altitude or medication side effects. Diagnosis include complete blood test, kidney function test, liver enzymes, vitamin B12 levels and erythrocyte sedimentation rate (ESR). 

Hematology Societies in USA

American Brain Tumor Association, USA; American Society for Radiation Oncology, USA; Association of Community Cancer Centers, USA; American Childhood Cancer Organization, USA; Michigan Society of Hematology and Oncology, USA; International Society on Thrombosis and Haemostasis, Inc, USA;  Childhood Brain Tumor Foundation, USA;  Lymphoma Research Foundation; American Cancer Society, USA

Myeloma:

Multiple myeloma/kahler’s disease is a cancer that forms in plasma cell. This disease can damage the bones, immune system, kidneys and red blood cell count. Symptoms are non-specific such as loss of appetite, bone pain, bone fractures, fatigue and fever. Treatments include chemotherapy, corticosteroids, radiation or a stem cell transplant.

Blood Transfusion:

Blood transfusion is a process in which donated blood/blood products are transferred into one’s circulation intravenously. This is a potentially lifesaving procedure used for various medical conditions to replace the lost components of blood due to surgery or injury. However, minor to severe problems do occur occasionally. Most common complications include allergic reactions, blood-borne infections, fever, acute immune hemolytic reaction. 

Hematology Societies in USA

American Head and Neck Society, USA;  Foundation for Women's Cancer, USA; Canadian Hematology Society, USA;  Colon Cancer Alliance, USA;  International Society for Laboratory Hematology, USA; International Society of Hematology, USA; Lung Cancer Foundation of America, USA; Mexican Society of Hematology, USA; American Society of Clinical Oncology, USA; Children's Tumor Foundation, USA

Anemia:

It is a condition that develops when the blood lacks enough ed blood cells or haemoglobin. This is a most common type of blood disorder. Manifestations may include fatigue, skin pallor, shortness of breath, light-headedness, dizziness. Treatment depends on the underlying diagnosis. Vitamin B supplements may be used for low vitamin levels. Iron supplements can be used for iron deficiency.

Hematology Societies in Asia-Pacific

Asian Cancer Foundation, Asia-Pacific; Asia Pacific Hematology Consortium, Asia-Pacific; Asian Society of Gynecologic Oncology, Asia-Pacific; Cancer Therapeutics Research Group, Asia-Pacific;  Black Sea Countries Coalition on Breast and Cervical Cancer Prevention, Asia-Pacific; Asian Hematology Association, Asia-Pacific

Thrombosis:

Formation of blood clot within the blood vessel obstructing the flow of blood through the circulatory system is termed as thrombosis. It is classified based on the type of blood vessel affected and the precise location of the blood vessel or the organ supplied by it. Treatment includes anticoagulation, thrombolysis, surgery, endovascular treatment, antiplatelet agents, targeting ischemia/reperfusion injury.

Hematology Societies in Asia-Pacific

The Thai Society of Hematology, Asia-Pacific; Asian and Pacific Federation of Organizations for Cancer Research and Control, Asia-Pacific; Asian Clinical Oncology Society: ACOS, Asia-Pacific; Asian Fund for Cancer Research, Asia-Pacific; Australasian Lung Cancer Trials Group, Asia-Pacific; Japanese Society of Hematology, Asia-Pacific; Pan Arab Hematology Association, Asia-Pacific

Biomarkers in Hematology and Oncology:

A cancer biomarker refers to a substance that indicates the presence of cancer in the body. A biomarker may be a molecule produced by a tumor or a specific response of the body to the presence of cancer. Epigenetic, proteomic, genetic, glycomic and imaging biomarkers can be used for cancer diagnosis, prognosis and epidemiology.

Hematology Societies in South Africa

World Health Organisation - Africa Region; Africa Cancer Foundation, Africa; Afrox - Improving Cancer Care in Africa; Oncology for Africa ONLUS - Afron, Africa; South African Clinical Haematology Society, Africa; African Organization for Research and Training in Cancer, Africa

HIV/AIDS:

Human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS), it harms the immune system by destroying the white blood cells that fight infection. A person with HIV infection may not notice any symptoms at the initial stage, followed by asymptomatic condition for prolonged period. As the infection progress, there will be an increasing risk of common infections like tuberculosis and other opportunistic infections. Thrombocytopenia is often associated with HIV infection.

Lymphoma:

Lymphoma is a cancer that begins in the lymphocytes the cells of immune system which fight against the infection. These cells occur in the lymph nodes, spleen, thymus, bone marrow and other parts of the body. Symptoms include enlarged lymph nodes, fatigue and weight loss. Diagnosis may include image tests, CT, MRI and positron emission therapy (PET).

Hematology Societies in South Africa

CHOC Childhood Cancer Foundation, South Africa; African Cancer Registry Network, Africa; African Journal of Cancer | Mediterranean Oncology Society, Africa; South African Society of Haematology, Africa; African Women’s Cancer Awareness Association, Africa;  Haematology and Oncology Society of Africa; Morocco - World Health Organization Africa 

Hemochromatosis:

It is a disorder wherein excess amount of iron is absorbed by the body. It is a chronic disorder last for years or be lifelong. This condition may lead to cancer, irregular heartbeat and cirrhosis of the liver. However, iron can be dropped to safe levels by regularly removing blood from the body. Common symptoms include pain in abdomen, fatigue, lethargy, reduced hormone production, darkening of skin and hepatitis.

European Hematology Societies:

International society of Hematology, European society of Hematology, British Society of Hematology, European society of Pediatric Hematology Oncology

Stem Cell Research:

Stem cells are undifferentiated cells capable of dividing and make an indefinite number of copies of themselves that serve numerous functions in different parts of the body. These cells are used for treating and understanding diseases such as to grow new cells in laboratory to replace damaged organs/tissues, to research why certain cells develop into cancer cells, test new drugs for safety and effectiveness. Types of stem cells used are embryonic stem cells, non-embryonic (adult) stem cells, induced pluripotent stem cells, cord blood stem cells and amniotic fluid stem cells. Applications of stem cell therapy are neurodegeneration, blood cell formation, wound healing, orthopaedics, infertility, brain and spinal cord injury.       

USA Hematology Societies:

The Canadian Hematology Society, American Society of Hematology, International Society for Laboratory Hematology,  Michigan society of Hematology, American Society of Clinical Oncology

Blood Tests:

A scientific examination of a sample of blood, generally advised by the physician for the diagnosis of illness, detection and measurement of drugs, assess your general state of health, to assess the functioning of the certain organs such as liver and kidneys.

Hematology Societies:

Haematology Society of Australia and New Zealand, Emirates society of Hematology, Armenian Hematology Association, Saudi Society for Hematology, Malaysian society of Hematology 

Blood Products:

A blood product may be defined as a therapeutic substance that is acquired from human blood. Some of the blood products are: Whole blood - which is rarely used in transfusion medicine. Blood components - Suspension of red blood cells, white blood cells and platelets; Plasma derivatives - Plasma proteins such as albumin, coagulation factor suspension and immunoglobulins.

Hematology Societies in Europe

European Society of Surgical Oncology, Europe; Association of European Cancer Leagues, Europe; European Academy of Cancer Sciences, Europe; European Prostate Cancer Coalition, Europe;  Organization of European Cancer Institute, Europe; European Organization for Research and Treatment of Cancer, Europe; International Society of Pediatric Oncology, Europe

Hematology Nursing:

Hematology nurses are instructed to provide nursing care to patients with blood diseases or disorders. Duties of the hematology nurse include: Encounter patients with blood diseases i.e. leukemia, haemophilia, sickle cell anemia and lymphoma, take medical histories, perform exams, Diagnose and treat blood diseases. They have authority to write prescriptions and order diagnostic laboratory work. Hematology nursing is closely related to oncology nursing.       

Hematology Societies in USA

American Cancer Society, USA; American Brain Tumor Association, USA; Association of Community Cancer Centers, USA;  American Childhood Cancer Organization, USA; American Society for Radiation Oncology, USA; International Society on Thrombosis and Haemostasis, Inc, USA;  Childhood Brain Tumor Foundation, USA;  Michigan Society of Hematology and Oncology, USA; Lymphoma Research Foundation

Pediatric Hematology:

It is a branch of medicine that deals with the cause, diagnosis, treatment and prevention of the diseases related to blood of infants, children and adolescents. Pediatric haematologists/Oncologists are specially trained to treat children with blood disorders and cancer.

Haematology and Pharma Industry:

The overall market for the haematological pharmaceuticals in top point as it is as often as possible foreseen to be improved over two or three decades. According to the overall market master, the hematology cure and definite market is depended upon to create at the rate of 7.5% from 2015-2020. A portion of the best drug store enterprises creating Biological Drugs and Generic Drugs fuse. Takeda Oncology, Bristol-Myers Squibb, Boehringer Ingelheim, Roche, Novartis, Celgene, Johnson and Johnson, Lilly, Takeda, AstraZeneca, Merck and Co., Amgen, Janssen bio tech, Pfizer, Bayer, Otsuka, Sanofi, Astellas, Eisai, AbbVie, Pharmacyclics, Merck KGaA and Incyte.

Hematology Societies in Asia-Pacific

Asian Hematology Association, Asia-Pacific; Asia Pacific Hematology Consortium, Asia-Pacific; Asian Society of Gynecologic Oncology, Asia-Pacific; Black Sea Countries Coalition on Breast and Cervical Cancer Prevention, Asia-Pacific; Cancer Therapeutics Research Group, Asia-Pacific; Asian Cancer Foundation, Asia-Pacific

Case reports and Epidemiology of Hematology & Hem-Oncology:

A Case report is a complete report of the signs, symptoms, diagnosis, treatment and follow-up of an individual patient. Hematology case reports do have genuinely helpful roles in medical research and evidence-based drugs. Specifically, they need facilitated recognition of recent diseases and adverse effects of treatments. Case reports encourage understanding the clinical range of unique or rare diseases, also as exceptional introductions of normal ailments. Case reports may likewise have an assignment to play in directing the personalization of medicines in clinical take after. For instance, Acquired Thrombotic Thrombocytopenic Purpura in a Patient with Pernicious Anemia was suggested by the report of a specific case.

Erythroblastosis fetalis:

A two blood groups system, that leads to erythroblastosis are Rh and ABO. Rhesus (Rh) is the protein that is inherited which is found over the surface of the red blood cells. People with Rh protein in the blood are Rh positive and without Rh protein are Rh negative. The two main causes of erythroblastosis fetalis: ABO incompatibility and Rh incompatibility.

Hematology Societies in South Africa

Africa Cancer Foundation, Africa;  Afrox - Improving Cancer Care in Africa; Oncology for Africa ONLUS - Afron, Africa; South African Clinical Haematology Society, Africa; World Health Organisation - Africa Region; African Organization for Research and Training in Cancer, Africa

Hemoglobinopathy:

Haemoglobin is the red protein present in the blood that supplies oxygen to tissues in vertebrates. Haemoglobin is produced by genes that control the expression of the haemoglobin protein. Defects in these genes produce abnormal haemoglobins and anemia these conditions are termed as hemoglobinopathy. It is a kind of genetic defect.

European Hematology Societies:

European society of Hematology, British Society of Hematology, International society of Hematology, European society of Pediatric Hematology Oncology

Hematologic Therapies:

It is the branch of medicine that deals with the study of blood, blood disease and the organs involved in forming blood. The diagnosis and treatment of hematological disorders is mainly managed by specialists in the field referred to as hematologists.

Hematology Societies in USA

Association of Community Cancer Centers, USA; American Brain Tumor Association, USA; Lymphoma Research Foundation; American Cancer Society, USA; American Childhood Cancer Organization, USA; Michigan Society of Hematology and Oncology, USA; International Society on Thrombosis and Haemostasis, Inc, USA; American Society for Radiation Oncology, USA; Childhood Brain Tumor Foundation, USA

HIV/AIDS:

Human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS). It harms the immune system by destroying the white blood cells that fight infection. A person with HIV infection may not notice any symptoms at the initial stage, followed by no symptoms for prolonged period. As the infection progress, there will be an increasing risk of common infections like tuberculosis and other opportunistic infections. Thrombocytopenia is often associated with HIV infection. HIV and SIV-associated thrombocytopenia arise through multiple mechanisms, including decreased platelet production, increased platelet destruction due to HIV-mimetic anti-platelet antibodies, and increased use of activated platelets.

Hematology Societies in South Africa

Haematology and Oncology Society of Africa; African Cancer Registry Network, Africa; Mediterranean Oncology Society, Africa; African Women’s Cancer Awareness Association, Africa;  Morocco - World Health Organization Africa; South African Society of Haematology, Africa; CHOC Childhood Cancer Foundation, South Africa

Hemochromatosis:

Hemochromatosis is a disease where excess iron is accumulated in the body by any cause. Commonly affected organs by hemochromatosis are heart, endocrine glands and liver. It can be diagnosed by Ferritin test, Liver function test, Iron test, UIBC, TIBC and Transferrin test. Hemochromatosis may present with the following clinical syndromes: Liver Cirrhosis, Arthritis, Testicular Failure, Joint and bone pain and Cardiomyopathy.

European Hematology Societies:

European society of Hematology, British Society of Hematology, International society of Hematology, European society of Pediatric Hematology Oncology

Blood Tests:

A scientific examination of a sample of blood, generally advised by the physician for the diagnosis of illness, for the detection and measurement of drugs, assess your general state of health, to assess the functioning of the certain organs such as liver and kidneys.

Types of blood test:

• Complete Blood Count
• Kidney Test: Renal Profile
• Cholesterol Test: Lipid Profile
• Blood Glucose Test
• Liver Function Test
• Blood Clotting Test

Hematology Societies in Europe

Association of European Cancer Leagues, Europe; International Society of Pediatric Oncology, Europe; European Academy of Cancer Sciences, Europe; European Society of Surgical Oncology, Europe; Organization of European Cancer Institute, Europe; European Organization for Research and Treatment of Cancer, Europe;  European Prostate Cancer Coalition, Europe

Haematology and Pharma Industry:

The overall market for the haematological pharmaceuticals in top point as it is as often as possible foreseen to be improved over two or three decades. According to the overall market master, the hematology cure and definite market is depended upon to create at the rate of 7.5% from 2015-2020. A portion of the best drug store enterprises creating Biological Drugs and Generic Drugs fuse. Takeda Oncology, Bristol-Myers Squibb, Boehringer Ingelheim, Roche, Novartis, Celgene, Johnson and Johnson, Lilly, Takeda, AstraZeneca, Merck and Co., Amgen, Janssen bio tech, Pfizer, Bayer, Otsuka, Sanofi, Astellas, Eisai, AbbVie, Pharmacyclics, Merck KGaA and Incyte.

Hematology Societies in Asia-Pacific

Asian Cancer Foundation, Asia-Pacific; Asia Pacific Hematology Consortium, Asia-Pacific; Asian Society of Gynecologic Oncology, Asia-Pacific; Cancer Therapeutics Research Group, Asia-Pacific;  Black Sea Countries Coalition on Breast and Cervical Cancer Prevention, Asia-Pacific; Asian Hematology Association, Asia-Pacific

Erythroblastosis fetalis:

A two blood groups system, that leads to erythroblastosis are Rh and ABO. Rhesus (Rh) is the protein that is inherited which is found over the surface of the red blood cells. People with Rh protein in the blood are Rh positive and without Rh protein are Rh negative. The two main causes of erythroblastosis fetalis: ABO incompatibility and Rh incompatibility.

Complications of erythroblastosis fetalis:

• Rapidly rising bilirubin
• Bilirubin Induced Neurological Dysfunction
• Prolonged hyperbilirubinemia
• Cerebral Palsy
• Neutropenia
• Kernicterus
• Thrombocytopenia
• Hemolytic anemia

Hematology Societies in USA

Association of Community Cancer Centers, USA; American Brain Tumor Association, USA; Lymphoma Research Foundation; American Cancer Society, USA; American Childhood Cancer Organization, USA; Michigan Society of Hematology and Oncology, USA; International Society on Thrombosis and Haemostasis, Inc, USA; American Society for Radiation Oncology, USA; Childhood Brain Tumor Foundation, USA

Hemoglobinopathy:

Haemoglobin is the red protein present in the blood that supplies oxygen to tissues in vertebrates. Haemoglobin is produced by genes that control the expression of the haemoglobin protein. Defects in these genes produce abnormal haemoglobins and anemia these conditions are termed as hemoglobinopathy. It is a kind of genetic defect.

Haemoglobin Variants (mutant forms):

• Hb S
• Hb E
• Hb C
• Hb H
• Hb J

Hematology Societies in South Africa

Haematology and Oncology Society of Africa; African Cancer Registry Network, Africa; Mediterranean Oncology Society, Africa; African Women’s Cancer Awareness Association, Africa;  Morocco - World Health Organization Africa; South African Society of Haematology, Africa; CHOC Childhood Cancer Foundation, South Africa

The Americas told the biggest offer of 45% of the worldwide hematology advertise at an expected $2,160 million out of 2015. Europe told the second biggest offer 26% of hematology advertise at an expected $300 million of every 2015.

The overall hematology feature is isolated into hematology items and organizations. Hematology items promote has been divided into instruments and consumables. The hematology instruments promote is furthermore separated into analyzers and slide strainers/makers. While the hematology consumables publicize has been assembled into three essential areas specifically; authorities, stains, and controls and calibrators. In addition, in light of the end-customers, the overall hematology promote has been separated into business affiliations, stay singular recuperating focuses, investigate associations, and clinical testing labs.

Different variables, for example, change of the high throughput hematology analyzers, growing apportionment of automated hematology instruments by diagnostics explore focuses, combination of basic stream cytometry techniques in current hematology analyzers, inventive degrees of progress and improvements in high affectability motivation behind brain (POC) hematology testing are moving the advancement of the overall hematology analyzers and reagents publicize. Of course, direct appointment of the impelled hematology instruments in the rising economies, hematology thing surveys, and the high cost of hematology analyzers are restricting the improvement of the overall market.

Beginning at 2014, North America holds the greatest offer of the overall market, trailed by Europe. In any case, the Asia-Pacific market is required to create at most significant CAGR of ~9.4% from 2014 to 2019. Different segments including making therapeutic administrations establishment, the broad patient masses, extending sponsoring/wander toward the headway of hematology things and building up a point of convergence of both worldwide and private players on the Asia-Pacific countries are engaging the advancement of the market in the Asia-Pacific locale.

Past Conference Report:

Hematologists 2017 Report

The success of the Hematology conferences has given us the prospect to bring the gathering one more time. Conference series LLC LTD hosted the “7^th World Hematologists Congress” during May 08-09, 2017 at Tryp Barcelona Airport, Parque de Negocios Mas Blau II, Plaza Plan Lake, 1-2, 08820 El Prat de Llobregat, Barcelona, Spain. The conference was focused on Hematology & Blood Disorders studies with the theme “A Step towards Excellence in Hematology Research”. The meeting engrossed a vicinity of comprehensive discussions on novel subjects like hematology, hematologic oncology, blood disorders, hematologic disorders, oncology, blood disorders diagnosis and treatment etc.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

• John Batchelor; Central Manchester Foundation Trust, UK
• Mingzhi Zhang; First Affiliated Hospital of Zhengzhou University, China
• Soad KAl Jaouni; King Abdulaziz University, Saudi Arabia
• Jean-Francois Schved; Montpellier University Hospital, France
• M Dahmani Fathallah; Arabian Gulf University, Bahrain

Conference series LLC LTD offers its heartfelt appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with Conference series LLC LTD and supported the conference in every aspect, without which the conference would not have been possible.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Hematologists 2017, Conference series LLC LTD would like to announce the commencement of the “17^th World Hematology Congress” to be held during November 25-26, 2019 at Paris, France. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Cancer Research.

Let us meet again @ World Hematology 2019